$B:G=*99?7F|;~!'(B2023-05-13 03:59:01
P-graph (1$B7o(B) | ||||
---|---|---|---|---|
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-2 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
620 | [$B>7BT9V1i(B] Graph theory approach to data-driven energy planning | K-2 | P-graph energy planning machine learning | 12/22 17:58:35 |
p-xylene (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
580 | $B30I=LL;@E@=hM}$r;\$7$?(BZn$BC4;}(BZSM-5$B?(G^$K$h$k%$%=%V%?%N!<%k$+$i$N(Bp-$B%-%7%l%sA*Br9g@.(B | 5-a | p-xylene biobutanol Zeolite | 12/22 16:26:28 |
P4O10/TiO2 photocatalyst (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-c (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
71 | P4O10$BC4;}NL$,(BCO2/H2O$B7O$K$*$1$k(BP4O10/TiO2$B8w?(G^$N(BCO2$B4T85@-G=$K5Z$\$91F6A(B | 5-c | P4O10/TiO2 photocatalyst CO2 reduction Infrared light | 12/13 14:44:42 |
Packed column (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 4-d (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
419 | $B5$1U8~N.7?= | 4-d | DAC Packed column Mass transfer | 12/21 20:39:53 |
Packed distillation column (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 6-c (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
3 | $B= | 6-c | Analogy analysis Heat and Mass Transfer Packed distillation column | 11/7 14:11:00 |
PAH interlayer (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 4-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
575 | Asymmetric Multilayered Structure Nanofilms Engineered via Amine-decorated Interlayered Interfacial Polymerization | 4-a | Nanofiltration Desalination PAH interlayer | 12/22 16:12:44 |
palladium membrane (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-d (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
485 | Pd$BKl?eAGF)2aKl?eEE2rAuCV$K$*$1$kEE6KIt$N2~NI(B | 5-d | palladium membrane hydrogen electrolysis | 12/22 11:56:41 |
Parallel Metabolic Pathway Engineering (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
489 | $BM-MQ2=3XJ* | 7-a | Metabolic Engineering Parallel Metabolic Pathway Engineering Escherichia coli | 12/22 12:17:23 |
Parameter calibration (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-f (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
594 | $B%Y%$%::GE,2=$K$h$k(BDEM$B%Q%i%a!<%?$N9;@5(B | 2-f | DEM Parameter calibration Bayesian optimization | 12/22 17:08:49 |
Pareto frontier (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 6-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
171 | $B?75;=Q$H%*%Z%l!<%7%g%s$r9MN8$7$?Cm | 6-b | Process design Multiobjective evaluation Pareto frontier | 12/20 11:12:56 |
partial molar volume (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 8-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
586 | Determination of the PMV values of OAME in supercritical carbon dioxide | 8-b | partial molar volume oleic acid methyl ester supercritical carbon dioxide | 12/22 16:52:32 |
partial nitrification (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 13-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
561 | $B9bJ,;R%2%k8GDj2=:Y6]$rMQ$$$?ItJ,>K2=%W%m%;%9(B | 13-b | nitrification gel partial nitrification | 12/22 15:49:55 |
particle (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-f (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
720 | $B7V8w%9%Z%/%H%k$rMQ$$$?HyN3;R6E=8>uBV2r@O$K4X$9$k8&5f(B | 2-f | fluorescence particle aggregation | 12/23 06:04:03 |
particle assembly (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-d (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
370 | $B6bB0%J%NN3;R=8@QBN$K$*$1$kN3;R4V5wN%$,1sJ}>lAj8_:nMQ$K5Z$\$91F6A(B | 12-d | Far-field coupling particle assembly plasmonic nanoparticle | 12/21 18:04:37 |
particle method (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
591 | $BM"Aw%7%_%e%l!<%7%g%s$N4J0W2rK!$N3+H/(B | 2-b | transport numerical simulation particle method | 12/22 17:02:37 |
Particle separation (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
375 | $BB?9& | 2-e | Microfluidic device Particle separation Porous substrate | 12/21 18:13:20 |
particle size (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 13-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
265 | $B2F5QHt3%$N9b29IUCe@-$NI>2A$H2r@O(B | 13-a | sewage sludge combustion fly ash adhesion at high temperatures particle size | 12/21 09:25:01 |
Particle Size Distribution (PSD) (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 3-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
398 | CO2$B$^$?$O(BH2O$B$,%Y%s%<%s$r86NA$H$7$?%+!<%\%s%V%i%C%/$N@8@.$K5Z$\$91F6A(B | 3-b | Carbon Black Particle Size Distribution (PSD) Morphology | 12/21 19:03:59 |
Particle Size Distribution(PSD) (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 3-b (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
397 | $BB?4DK'9aB2C:2=?eAG$r86NA$H$7$?G.J,2r$G@8$8$k$9$9$K$D$$$F$N8!F$(B | 3-b | Soot Particle Size Distribution(PSD) Polycyclic Aromatic Hydrocarbons(PAHs) | 12/21 19:03:52 |
Particle suspension (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-e (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
455 | $BN3;R7|By1U$N$;$sCGN.$l$K4X$9$k3J;R%\%k%D%^%s%7%_%e%l!<%7%g%s(B | 2-e | Particle suspension Lattice Boltzmann Method Viscosity | 12/22 10:22:18 |
549 | $BHsDj>oQrCGN.$l$K$*$1$kN3;R7|By1U$N | 2-e | Unsteady shear Effective viscosity Particle suspension | 12/22 15:16:21 |
particles (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
164 | $BN3;R4^M-1UE)$N8GBNI=LL>WFM;~$K$*$1$k1UE)FbN3;R$N5sF0I>2A(B | 2-a | Droplet impact particles collision | 12/19 19:37:03 |
PC-12 (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
453 | $BG[8~@-%3%i!<%2%s%U%!%$%P! | 7-e | Collagen fiber PC-12 nerve guide | 12/22 10:02:43 |
PEFC (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 9-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
78 | $B9b29H/EE>r7o$N(BPEFC$BC1%;%kFbO"@.8=>]$K5Z$\$9F0:n29EY$H%;%Q%l!<%?!<8|$_$N1F6A2r@O(B | 9-e | PEFC Separator Thickness High Temperature Operation | 12/13 18:27:26 |
Peng Robinson (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 1-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
307 | Cubic Plus GE $B%b%G%k$K$h$k5$1UJ?9U$NAj4X(B | 1-a | Peng Robinson equation of state second virial coefficient | 12/21 14:48:47 |
Peng-Robinson EoS (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B HQ-21 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
361 | [$B0MMj9V1i(B] $B?M9)%K%e!<%i%k%M%C%H%o!<%/$K$h$k(BPeng-Robinson$B>uBVJ}Dx<0$NAj8_:nMQ%Q%i%a!<%?M=B,(B | HQ-21 | Peng-Robinson EoS Artificial neural network | 12/21 17:47:08 |
Pentane Isomers (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 4-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
347 | $B%7%j%+%i%$%HKl$K$h$k(Bn-/iso-Pentane $B0[@-BNJ,N%$H(BCFD$B2r@O(B | 4-a | Membrane separation Pentane Isomers CFD | 12/21 17:06:17 |
peptide (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
5 | $B%*%j%4%Z%W%A%I$H93??6]Lt$N<+8JAH?%2=$rMxMQ$7$?6] | 12-e | peptide self-assembly antimicrobials | 11/10 17:14:51 |
450 | $B%8%Z%W%A%IJ*@-%G!<%?2r@O$K$h$k(BLC$BMO=P;~4V$NM=B,(B | 7-h | peptide LC-MS/MS machine learning | 12/22 09:51:12 |
Peptide amphiphile (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
195 | $B$,$s:YK&Fb2a>jH/8=%-%J!<%<$K$h$k93$,$s%Z%W%A%I;i | 7-e | Peptide amphiphile anti-cancer overexpressed kinase | 12/20 15:28:55 |
peptide fiber (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-4 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
741 | [$B0MMj9V1i(B] Enzyme-reactive supramolecular peptide fibers for potential vaccine applications | K-4 | peptide fiber protein delivery immunization | 12/26 19:16:32 |
peptide screening (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
92 | $B@~0]2j:YK&J,2=M^@)%Z%W%A%I%9%/%j!<%K%s%07O$N3+H/(B | 7-e | fibrosis myofibroblast peptide screening | 12/15 14:10:15 |
Peptides (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
249 | $B%F%H%i%9%Q%K%s(BCD9$B7k9g@-%Z%W%A%I$K$h$k%(%/%=%=!<%`$N7A@.@)8f(B | 7-e | Tetraspanin Peptides Cancer cell | 12/20 19:58:21 |
Perfusion culture (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-a (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
205 | $B=ENOD@9_7?>.7?^uN.G]M\AuCV$rMQ$$$?%0%k%?%_%sIT4^G]CO$K$*$1$k(BCHL-YN$B:YK&G]M\(B | 7-a | Perfusion culture Mammalian cells Antibody production | 12/20 15:57:59 |
438 | $B%9%U%'%m%$%I$N7A@.!&4CN.G]M\!&4Q;!!&2s<}$r8zN(2=$9$kB?9&@-%A%c%s%P!<$N3+H/(B | 7-a | Microfluidic device Perfusion culture Porous microchamber | 12/21 23:54:19 |
Peritoneal dialysis (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
515 | $BJ"KlF)@O$rLOJo$7$?7l1U>t2=%b%8%e!<%k$N@_7W0x;R$HMO | 7-e | Wearable blood purification Peritoneal dialysis Mass transfer | 12/22 13:50:04 |
Permeability test (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
88 | $BF)2a@-;n830BDj2=$N$?$a$N:YK&7ABV>pJs2r@O(B | 7-e | Permeability test Endothelial cells Morphology | 12/15 10:52:39 |
permeation (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
286 | $B%j%-%C%H%^!<%V%k$rMQ$$$FD4@=$7$?%P%/%F%j%"%;%k%m!<%9Kl$NF)2a@-@)8f(B | 12-a | bacterial cellulose membrane permeation | 12/21 12:00:02 |
Perovskite (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-3 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
733 | [$B>7BT9V1i(B] Development of high-efficiency perovskite solar cells by solution printing processes | K-3 | Perovskite Photovoltaics Energy conversion efficiency | 12/26 13:02:39 |
Peroxidase (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
679 | $B%Z%k%*%-%7%@!<%<4^M-%$%s%/$H;Y;}:`NA$H$N8r8_2!=P%P%$%*%W%j%s%F%#%s%0 | 7-e | 3D bioprinting Support material Peroxidase | 12/22 20:16:57 |
Personalized medicine (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 6-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
395 | $BBn>e>{:^@=B$$N$?$a$NJ4BNJ*@-$K4p$E$/IJ | 6-a | Personalized medicine Process operation Statistical model | 12/21 18:54:50 |
Pervaporation (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 4-a (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
442 | MFI membranes for separation of organic solution (Shibaura Inst. Tech.) ($B3X(B)$B!{(BCaralin Irmariza Shafitri$B!&(B | 4-a | MFI membranes Pervaporation Organic solvent separation | 12/22 00:13:14 |
478 | Pervaporation membranes of asymmetric surface characteristics for ethanol/water separation | 4-a | Pervaporation Molecular simulation Ethanol/water separation | 12/22 11:32:45 |
PETase (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
296 | PETase$B$r:YK&I=AX$KDs<($7$?BgD26]$N3+H/(B | 7-a | PETase Escherichia coli cell surface display | 12/21 13:26:48 |
PFG-NMR (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B HQ-21 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
722 | [$B0MMj9V1i(B] Na$B7OEE2r1U$N<+8J3H;678?t7WB,$*$h$S(BLi$B7OEE2r1U$H$NJ*M}2=3XE*FC@-$NHf3SI>2A(B | HQ-21 | Na-based electrolyte Self-diffusion coefficient PFG-NMR | 12/23 21:39:42 |
pH responsiveness (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-c (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
356 | $B>:297?%2%k2=:^(BPNIPAM$B%3%]%j%^!<%J%N%2%k$X$N(BpH$B1~Ez@-$NIUM?(B | 12-c | nanogel thermogelling pH responsiveness | 12/21 17:35:09 |
Phage display (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-a (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
551 | $B5!3#3X=,$r;X?K$H$7$??J2=J,;R9)3X$K$h$k93BNCGJR$N7k9g5!G=AO=P(B | 7-a | Antibody fragments Phage display Machine learning | 12/22 15:18:26 |
667 | $B5!3#3X=,$r | 7-a | Antibody mimetics Phage display Machine-learning | 12/22 19:38:13 |
Pharmaceuticals (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 1-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
353 | $BFq?eMO@-@8BN3h@-@.J,%U%i%\%+%o%$%s(BA$B$N?eMO@-$N8~>e$rL\E*$H$7$?=uMOG^E:2C$K$h$kMO2rEYB,Dj(B | 1-a | Solubility Cyclodextrin Pharmaceuticals | 12/21 17:19:06 |
phase change material (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-f (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
155 | $B%;%k%m!<%9%J%N%U%!%$%P!<$r3L:`$H$7$?C_G.%^%$%/%m%+%W%;%k$N3+H/(B | 12-f | microcapsule cellulose nanofiber phase change material | 12/19 17:35:35 |
Phase equilibria (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 1-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
465 | 2$B1UAj$r7A@.$9$k(B2$B@.J,7O$NAjJ?9U$NB,Dj!!!=%a%?%N!<%k(B+$B%7%/%m%X%-%5%s!$(B2-$B%V%?%N!<%k(B+$B?e7O!=(B | 1-a | Phase equilibria two-liquid phase Activity coefficient model | 12/22 11:01:48 |
phase separation (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
318 | Korteweg$BNO$rH<$&AjJ,N%$KM65/$5$l$k(BViscous fingering$B$N%H%]%m%8%+%kJQ2=$K4X$9$k?tCM2r@O(B | 2-a | phase separation viscous fingering Korteweg force | 12/21 15:32:52 |
707 | $B%j%]%=!<%`$NAjJ,N%$K$h$k6I=jE*$JI=LLH?1~NN0h$N@)8f$H1~MQ(B | 12-a | Phase separation liposome | 12/22 22:48:30 |
Phase transition (3$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-j (3$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
42 | Plasticizing effect of degradable block copolymers with low-temperature formability | 12-j | block copolymer phase transition plasticizer | 12/8 22:06:20 |
81 | Poly(1,5-dioxepan-2-one)-b-poly(L-lactide)$B$N2C052<$G$NN.F0FC@-(B | 12-j | block copolymer phase transition plasticizer | 12/14 09:56:47 |
289 | $B%]%j%+%W%m%i%/%H%sM6F3BN$H%]%j(BL$BF};@%V%m%C%/6&=E9gBN$N2=3X9=B$$H05NOM65/AjE>0\(B | 12-j | Block copolymer Phase transition Pressure | 12/21 12:41:59 |
Phenobarbital (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
311 | $BJ,;R%$%s%W%j%s%H%]%j%^!<8GDj%0%i%U%!%$%HEE6K$rMQ$$$?9b46EY%U%'%N%P%k%S%?!<%k%;%s%5$N%b%N%^! | 7-e | Phenobarbital Therapeutic Drug Monitoring Molecularly Imprinted Polymers | 12/21 14:52:26 |
phenotypic analysis (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
73 | $B?J9T@-3K>e@-Kcac%b%G%k:YK&$N$?$a$N:YK&2hA|I=8=7?2r@O(B | 7-e | phenotypic analysis Morphology neurodegenerative disease | 12/13 16:41:21 |
phospholipid polymers (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-4 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
737 | [$B0MMj9V1i(B] Preparation of redox phospholipid polymers for cancer therapy | K-4 | cancer therapy redox phospholipid polymers | 12/26 17:15:29 |
Phosphoric Acid - Modified Activated Carbon (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 4-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
159 | $B%j!<%/%"%s%b%K%"%,%92s<}$K8~$1$?%j%s;@=$>~3h@-C:$K$h$k%"%s%b%K%"5[C&Ce%a%+%K%:%`$N2r@O(B | 4-e | Phosphoric Acid - Modified Activated Carbon Leaked Ammonia Adsorption/Desorption | 12/19 17:50:07 |
photo catalyst (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SS-1 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
213 | [$B>7BT9V1i(B] $B?M9)8w9g@.7?@=IJ5;=Q$N3+H/>u67$HE8K>(B | SS-1 | photo catalyst water splitting hydrogen | 12/20 16:41:56 |
photo-thermal effect (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 8-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
467 | $B%+!<%\%s%V%i%C%/$r4^M-$9$k%(%"%m%2%k$rMQ$$$?8wG.JQ49$K$h$kBg5$Cf(BCO2$B$N2s<}(B | 8-e | aerogel photo-thermal effect CO2 capture | 12/22 11:04:35 |
photocatalyst (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
105 | $BE4%]%k%U%#%j%s$rAH$_9~$s$@B?9& | 5-a | photocatalyst CO2 reduction heterogeneous catalyst | 12/16 10:44:29 |
622 | $B9bJ,;R%2%kFb$G9g@.$7$?N22=F | 12-e | hydrogfel copper sulfide photocatalyst | 12/22 18:05:00 |
Photocatalysts (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 12-c (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
32 | $B%U%C2=?eAG%U%j!<$JJ#AX2=(BTi3C2$B!!(BMXene-TiO2$BJ#9g8w?(G^$ND>@\9g@.(B | 12-c | Ti3C2 MXene TiO2 Photocatalysts | 12/7 11:41:35 |
Photocatalytic membrane reactor (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-1 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
251 | [$B>7BT9V1i(B] In-situ growth of MIL-88B(Fe,Co) for photocatalytic membrane reactor with high permeance flux and phenol removal efficiency | K-1 | MIL-88B(Fe) Photocatalytic membrane reactor degradation | 12/20 20:09:41 |
photopolymerization (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-i (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
665 | $BN3;R= | 5-i | flow reactor immobilized catalyst photopolymerization | 12/22 19:28:18 |
photoreactive material (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 7-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
176 | $B:YK&4VAj8_:nMQ$rAO=P$9$k@8BND>8rE*$J8wH?1~@-I=LL(B | 7-e | photoreactive material cell-cell interaction immune therapy | 12/20 12:36:43 |
Photovoltaic (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 13-d (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
106 | $B=8G.5!9=IU$-?bD>@_CVB@M[8w%b%8%e!<%k$NF3F~8z2L(B | 13-d | Photovoltaic Heat Collection Renewable Energy | 12/16 13:24:37 |
photovoltaic panel (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 13-e (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
108 | PV$B%;%k%7!<%HJ4:UJ*$+$i$N | 13-e | recycle tin photovoltaic panel | 12/16 15:42:04 |
Photovoltaics (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B K-3 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
733 | [$B>7BT9V1i(B] Development of high-efficiency perovskite solar cells by solution printing processes | K-3 | Perovskite Photovoltaics Energy conversion efficiency | 12/26 13:02:39 |
physical meaning (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 2-e (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
39 | $BN.BNCf$N1?F0NLM"Aw(B($B?t<0$N0UL#$9$kJ*M}E*8=>]$*$h$S6-3&>r7o(B) | 2-e | Navier-Stokes equation, momentum physical meaning | 12/8 20:22:20 |
40 | $BN.BNCf$N3Q1?F0NLM"Aw(B($B?t<0$N0UL#$9$kJ*M}E*8=>]$*$h$S6-3&>r7o(B) | 2-e | Equation of vorticity transport angular-momentum physical meaning | 12/8 20:31:10 |
physical property (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 1-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
134 | $B? | 1-a | deep learning physical property prediction | 12/19 12:43:47 |
physics informed machine learning (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B 5-a (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
659 | $B2=3XH?1~%K%e!<%i%k%M%C%H%o!<%/$K$h$k>/?t!&7gB,%G!<%?%;%C%H$+$i$NB.EYO@%b%G%k9=C[(B | 5-a | physics informed machine learning kinetic model data-driven | 12/22 19:13:36 |